Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Eli Lilly and Company Shares Fall After GLP-1 Sales Miss Expectations

January 28, 2025
Investors were left disappointed as Eli Lilly and Company (LLY) reported lower-than-expected sales of their GLP-1 diabetes drugs. The stock price of LLY dropped as a result, causing concern among shareholders. However, industry experts believe this is just a temporary setback for the pharmaceutical giant. With a strong pipeline of innovative drugs in development, Eli Lilly is expected to bounce back soon. Investors are advised to consult professionals from Stocks Prognosis for a forecast on the future movement of LLY stocks.

Find out how the ELI LILLY AND COMPANY rate is expected to change

Get Forecast for LLY

Investor opinions & comments:

I'm not surprised by the drop in sales. The diabetes drug market is highly competitive
— from WealthyWhitney at 01-31-2025 20:52
I'm skeptical of Eli Lilly's ability to bounce back quickly. The pharmaceutical industry is unpredictable
— from SmartSabrina at 01-31-2025 04:47
I'm interested to see what impact this will have on Eli Lilly's overall financial performance
— from BudgetBrad at 01-30-2025 16:31
I wonder how this will affect Eli Lilly's competitors in the diabetes drug market
— from InvestorTom at 01-29-2025 18:09
I'm not convinced that Eli Lilly's pipeline of innovative drugs will be enough to offset this sales disappointment
— from InvestorIsabella at 01-29-2025 06:27
I'm curious to know how Eli Lilly plans to regain investor confidence after this setback
— from MoneyJoe at 01-29-2025 05:03
If you want to leave a comment, then you need Login or Register





Other news for LLY

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....



Related news

MRKJanuary 2, 2025Merck & Co., Inc. Shows Strong Fundamentals Despite Temporary Stock Weakness  ~2 min.

Merck & Co., Inc., commonly known as Merck, has faced temporary weakness in its stock recently despite its strong fundamentals....

REGNJanuary 22, 2025Regeneron Pharmaceuticals REGN Faces Securities Class Action After Losing 9 Billion Value Following Q3 2024 Earnings Report  ~1 min.

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) is facing a securities class action after suffering a massive value loss of 9 billion following their Q3 2024 earnings report....

LLYNovember 14, 2024Eli Lilly and Company LLY: Breaking Barriers in Pharma Industry  ~2 min.

Eli Lilly and Company, a leading pharmaceutical giant, has recently achieved a major milestone that has left investors disappointed....

MRKFebruary 11, 2025Merck Stock Slumps as Q4 Profits 2025 Forecast Fall Short  ~2 min.

Merck & Co., Inc. (MRK) reported its financial results for the fourth quarter and full-year 2024, and the numbers have disappointed investors....

GOOGLFebruary 5, 2025Google's Parent Company, Alphabet Inc. (GOOGL), Expected to Bounce Back After Disappointing Cloud Sales  ~2 min.

Alphabet Inc., the parent company of Google, saw its stock price fall after disappointing cloud sales dragged down its revenue....